EAAs (Essential Amino Acids), Liver and Kidneys: Are They Safe?
Essential amino acid (EAA) supplements have become a popular alternative to whey and BCAAs, often sipped throughout the day during training. A common worry is whether this extra amino acid load strains the liver or kidneys. The editorial team has examined what the research says for healthy people and where genuine caution is needed.
What EAAs are and how much people take
Nine amino acids are classed as essential because the human body cannot make them: leucine, isoleucine, valine, lysine, methionine, phenylalanine, threonine, tryptophan and histidine. They must come from food. EAA supplements provide these building blocks in free form, usually as a flavoured powder mixed with water.
Research on muscle protein synthesis shows that EAAs, and leucine in particular, are the main dietary triggers of muscle building. Unlike BCAA products, which contain only three amino acids, EAA formulas provide the full set needed to actually build new protein, which explains their growing popularity.
Typical servings range from about 6 to 15 grams. In nutritional terms, that is equivalent to the essential amino acid content of a modest serving of meat or whey protein. Even several servings per day add an amount of protein that sits well within the range of ordinary high-protein diets.
This context matters: from the perspective of the liver and kidneys, EAAs are processed in the same way as amino acids from food. The question is therefore not whether EAAs are uniquely dangerous, but whether a high overall protein intake poses risks, and for whom.
How the liver and kidneys handle amino acids
Absorbed amino acids travel first to the liver through the portal vein. The liver uses some for protein synthesis, passes others to the circulation for muscle and other tissues, and breaks down the surplus. Branched-chain amino acids are an exception: they are mainly metabolised in muscle rather than the liver.
When amino acids are broken down for energy, their nitrogen is converted to ammonia, which is toxic. The liver detoxifies ammonia by turning it into urea through the urea cycle. Urea then travels in the blood to the kidneys, which excrete it in urine.
A higher protein intake increases urea production and, temporarily, the kidneys' filtration rate. This phenomenon, called hyperfiltration, is a normal physiological adaptation, similar to the way the heart beats faster during exercise. In healthy kidneys, it has not been shown to cause damage.
Blood tests in people on high-protein diets may show slightly higher urea levels, and in those with lots of muscle, higher creatinine. Neither result automatically indicates kidney damage; interpretation needs to take diet, muscle mass and hydration into account.
Evidence in healthy people
Several controlled studies have examined high-protein diets in resistance-trained individuals. In one year-long crossover study, trained men consuming around 2.5–3.3 g of protein per kilogram of body weight per day showed no harmful changes in blood lipids, liver function markers or kidney function compared with their usual diet.
A systematic review and meta-analysis published in the Journal of Nutrition in 2018 found that higher protein intakes did not lead to a decline in glomerular filtration rate in healthy adults compared with lower or normal intakes. This is one of the more robust pieces of evidence on the topic.
Specific long-term trials of EAA supplements are limited, but short-term clinical studies in older adults and patients, often using 10–15 g doses daily for weeks or months, have not reported liver or kidney toxicity. Given that EAAs are simply part of normal dietary protein, there is no mechanistic reason to expect them to be more harmful than equivalent protein from food.
The International Society of Sports Nutrition position stand on protein concludes that intakes of 1.4–2.0 g/kg per day are safe and sufficient for most exercising individuals, and that there is no evidence of harm in healthy people at higher intakes over the periods studied.
Who should be careful
The picture changes for people with pre-existing disease. In chronic kidney disease (CKD), international guidelines such as KDIGO suggest moderating protein intake for many patients not on dialysis, because hyperfiltration can accelerate damage in kidneys that are already compromised. EAA supplements add to this load.
In liver disease the situation is nuanced. Patients with cirrhosis often need adequate or even increased protein to prevent muscle loss, and the ESPEN guideline on liver disease supports BCAA supplementation in certain cases. However, those prone to hepatic encephalopathy need specialist dietetic management, not self-chosen supplements.
| Group | Concern | Recommendation |
|---|---|---|
| Healthy adults | No evidence of harm at typical doses | Count EAAs as part of daily protein |
| Chronic kidney disease | Extra nitrogen load and hyperfiltration | Only with renal dietitian approval |
| Cirrhosis or advanced liver disease | Ammonia handling, encephalopathy risk | Specialist-guided nutrition only |
| Phenylketonuria (PKU) | Cannot metabolise phenylalanine | Avoid standard EAA products |
| Maple syrup urine disease | Cannot break down BCAAs | Avoid; metabolic specialist care |
| Single kidney, diabetes, hypertension | Higher baseline CKD risk | Check kidney function first |
People with diabetes, high blood pressure or a family history of kidney disease are at higher risk of developing CKD, sometimes without symptoms. For them, a simple blood test (eGFR) and urine test (albumin-creatinine ratio) before increasing protein substantially is a sensible precaution.
Practical guidance for safe use
For healthy adults, EAA supplements are best seen as a convenient source of high-quality protein, not as a separate category with its own rules. The total daily protein intake, from food and all supplements combined, is what counts.
- Include EAA servings when calculating your daily protein target.
- Stay well hydrated, particularly during heavy training and in warm weather.
- Choose products from reputable manufacturers, ideally batch-tested if you compete.
- Check the label for added stimulants, which are common in "energy" EAA blends.
- If you have a known kidney or liver condition, talk to your doctor before use.
When having blood tests, mention that you follow a high-protein diet and use supplements. Creatine supplementation, for instance, raises serum creatinine, which can make eGFR appear falsely low. Cystatin C is an alternative marker that is less affected by muscle mass and creatine use.
Signs that warrant medical review include persistent swelling of the ankles, foamy urine, a marked change in urine output, yellowing of the skin or eyes, or dark urine. These are not expected effects of amino acid supplements and should be investigated.
Conclusions of the editorial team
For healthy people, EAA supplements at typical doses do not appear to harm the liver or kidneys. They are processed like any other dietary protein.
Research on high-protein diets in trained individuals shows no decline in kidney function or adverse liver markers over the periods studied.
Caution is essential for people with chronic kidney disease, advanced liver disease and inherited amino acid disorders such as PKU. Those at higher risk of kidney disease should check their kidney function before significantly increasing protein intake.
For further reading, the editorial team suggests our articles on EAAs versus BCAAs, on interpreting creatinine and eGFR in athletes, and on protein requirements during a cut.
References
- Antonio J, Ellerbroek A, Silver T, et al. A high protein diet has no harmful effects: a one-year crossover study in resistance-trained males. J Nutr Metab. 2016;2016:9104792.
- Devries MC, Sithamparapillai A, Brimble KS, et al. Changes in kidney function do not differ between healthy adults consuming higher- compared with lower- or normal-protein diets: a systematic review and meta-analysis. J Nutr. 2018;148(11):1760–1775.
- Jäger R, Kerksick CM, Campbell BI, et al. International Society of Sports Nutrition position stand: protein and exercise. J Int Soc Sports Nutr. 2017;14:20.
- Plauth M, Bernal W, Dasarathy S, et al. ESPEN guideline on clinical nutrition in liver disease. Clin Nutr. 2019;38(2):485–521.
- Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. 2024;105(4S):S117–S314.
- Wolfe RR. Branched-chain amino acids and muscle protein synthesis in humans: myth or reality? J Int Soc Sports Nutr. 2017;14:30.
